U.S. Congress - News Articles for H.R.2900 Food and Drug Administration Amendments Act of 2007
H.R.2900 - Food and Drug Administration Amendments Act of 2007
To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes. view all titles (14)
All Bill Titles
- Short: Pediatric Medical Device Safety and Improvement Act of 2007 as passed house.
- Short: Best Pharmaceuticals for Children Act of 2007 as introduced.
- Short: Food and Drug Administration Amendments Act of 2007 as passed house.
- Short: Best Pharmaceuticals for Children Act of 2007 as passed house.
- Short: Pediatric Research Equity Act of 2007 as passed house.
- Short: Prescription Drug User Fee Amendments of 2007 as passed house.
- Official: To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes. as introduced.
- Short: Medical Device User Fee Amendments of 2007 as introduced.
- Short: Pediatric Medical Device Safety and Improvement Act of 2007 as introduced.
- Short: Pediatric Research Equity Act of 2007 as introduced.
- Short: Food and Drug Administration Amendments Act of 2007 as introduced.
- Short: Prescription Drug User Fee Amendments of 2007' as introduced.
- Short: Medical Device User Fee Amendments of 2007 as passed house.
- Short: Prescription Drug User Fee Amendments of 2007 as introduced.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
- Newest First
- Oldest First
- Highest Rated
Sort By
Congress acting to help stressed housing projects
Congress should pass The Food and Drug Revitalization Act of 2007 (S 1082) and The Food and Drug Administration Amendments Act of 2007 (HR 2900) in ...
Sept. 30 Deadline Drives FDA Reauthorization Bill
Both the House and Senate have passed FDA reauthorization bills ( HR 2900 , S 1082 ), and congressional leaders have assured the agency that Congress will ...
Congress urged to act on clinical trial registries and databases
Public Citizen says that the House bill, HR 2900, is better than the Senate’s version, S 1082, because it requires a summary of clinical trials for patients ...
Lawmakers Push for Final Passage of PDUFA Reauthorization
The Senate passed its version of the bill, S. 1082, in May, while the House passed its version, HR 2900, earlier this month. Since there are a number of ...
Media Issues Heat Up On Capitol Hill As The Legislative Summer ...
The full House Energy and Commerce Committee approved the amended legislation on June 21, and the House passed the bill (now HR 2900) on July 11 by a vote ...
Congress Should Give FDA Authority to Regulate Compounding ...
A provision allowing the FDA to regulate rogue pharmacies that are mass-compounding drugs should be included in S. 1082 and HR 2900, bills that would ...
Public Citizen Calls for Clinical Trial Registry and Results ...
Two bills that would regulate results and registry databases, HR 2900 and S. 1082, are pending before a conference committee. A spokesman for the Senate ...
Follow-On Biologics Legislation Will Delay PDUFA Bill, Lawmakers Say
The Senate version of the bill, S. 1082, contains a placeholder to insert follow-on biologics legislation, while the House bill, HR 2900, does not. ...
Bill to Strengthen FDA Passes House
The bill, HR 2900, will next go to a conference committee to work out differences with the Senate version (S. 1082), which was passed in May 2007. ...
Public Citizen: Strong Law Needed to Require Clinical Trial ...
The House bill, HR 2900, is better than the Senate bill, S. 1082, in creating and enforcing a registry and results database. Unlike the Senate version, ...
Strong Federal Legislation Necessary to Require Clinical Trial ...
The House bill, HR 2900, is better than the Senate bill, S. 1082, in creating and enforcing a registry and results database. Unlike the Senate version, ...
House of Representatives Passes Drug Safety Bill
The bill, known as HR 2900 "FDA Amendments Act of 2007" will now be sent onto the Senate, where there is another bill SS 1082, the FDA Revitalization Act. ...
Thomas Voting Reports
... action when harmful complications develop. A yes vote was to pass HR 2900. Voting yes: Inslee, Larsen, Baird, Hastings, McMorris Rodgers, Reichert, Smith.
How Texans voted in DC
Food and drug safety: Passed, 403-16, a bill (HR 2900) to give the Food and Drug Administration new authority to protect the US population against unsafe ...
Roll-call votes by members of Congress from the area:
FOOD AND DRUG SAFETY (HR 2900): Voting 403-16, the House approved giving the Food and Drug Administration new authority to protect the US population from ...
Congress To Pass Bill to Improve Drug Safety
The House is to take a final vote this evening on passage of HR 2900, the Food and Drug Administration Amendments Act of 2007, and positive debate today ...
House to Approve Major Drug Safety, FDA Reform Package; Now Up to ...
The House is to take a final vote this evening on passage of HR 2900, the Food and Drug Administration Amendments Act of 2007, and positive debate today ...
Defective Drugs & FDA are Target of Food & Drug Administration Act ...
If signed by President Bush in its current form, the Food and Drug Administration Act of 2007 (HR 2900) would usher in the biggest changes the FDA has seen ...
House Passes PDUFA Reauthorization Bill
The bill, HR 2900, was debated under a suspension of rules, preventing the addition of any amendments to the legislation. It now will go to a conference ...
FDA tyranny to become law: HR.2900 analysis by Richards and Adams
On July 11, 2007, the US House of Representatives passed HR 2900, blocking debate on the law and preventing the introduction of any amendments that might ...
House to Approve Major Drug Safety, FDA Reform Package; Now Up to ...
The House is to take a final vote this evening on passage of HR 2900, the Food and Drug Administration Amendments Act of 2007, and positive debate today ...
House Floor Procedure for FDA Overhaul Bill Reflects Depth of ...
The legislation ( HR 2900 ), which would reauthorize an FDA program to review and approve new drugs, is a drug industry priority. But the Democratic-written ...
Emergency Alert: House Democrats Selling Out Dietary Supplements
HR.2900 is now scheduled to be voted on in the House on Wednesday, July 11. It is imperative to keep up the pressure in the action steps below so that the ...
House Vote Set Wednesday on First Major Prescription Drug Safety ...
The House is slated to vote Wednesday on HR 2900, the Food and Drug Administration Amendments Act of 2007. The Senate already has passed its version of the ...
House Vote Set Wednesday on First Major Prescription Drug Safety ...
The House is slated to vote Wednesday on HR 2900, the Food and Drug Administration Amendments Act of 2007. The Senate already has passed its version of the ...
House of Representatives Set to Vote on Tough New Drug Testing ...
The House of Representatives is scheduled to vote Wednesday on HR 2900, the Food and Drug Administration Amendments Act of 2007. ...
House to Hold PDUFA Vote Wednesday
The bill, HR 2900, will come up for a vote under suspension of the rules, a procedural move that prevents the addition of any amendments to the legislation, ...
House Vote Set Wednesday on First Major Prescription Drug Safety ...
The House is slated to vote Wednesday on HR 2900, the Food and Drug Administration Amendments Act of 2007. The Senate already has passed its version of the ...
What might that little pill do?
To read the bill for yourself, go to http://thomas.loc.gov/ and type HR 2900 in the "Search Bill Text" window; then click on "Bill Number" and hit the ...
House Tackles Drug Safety, Student Loans and Other Domestic Issues
The most sweeping agenda item is an overhaul of Food and Drug Administration regulatory authority ( HR 2900 ) that would add new post-marketing surveillance ...
Vote on This Bill
-
Share This Bill
More Share via Email
